{"id":17241,"date":"2023-11-07T19:37:57","date_gmt":"2023-11-07T18:37:57","guid":{"rendered":"https:\/\/www.hematostat.net\/?p=17241"},"modified":"2024-01-02T19:42:29","modified_gmt":"2024-01-02T18:42:29","slug":"annonce-de-lobtention-dune-autorisation-de-mise-sur-le-marche-conditionnelle-dans-lue-pour-jaypirca-pirtobrutinib","status":"publish","type":"post","link":"https:\/\/www.hematostat.net\/en\/annonce-de-lobtention-dune-autorisation-de-mise-sur-le-marche-conditionnelle-dans-lue-pour-jaypirca-pirtobrutinib\/","title":{"rendered":"Annonce de l\u2019obtention d\u2019une autorisation de mise sur le march\u00e9 conditionnelle dans l\u2019UE pour Jaypirca\u00ae (pirtobrutinib)"},"content":{"rendered":"<ul>\n<li>Lilly annonce l\u2019obtention d\u2019une autorisation de mise sur le march\u00e9 conditionnelle dans l\u2019UE pour Jaypirca\u00ae(pirtobrutinib), le premier et le seul inhibiteur r\u00e9versible de la tyrosine kinase de Bruton (BTK) approuv\u00e9 par l\u2019Agence Europ\u00e9enne du M\u00e9dicament (EMA), pour les patients adultes atteints de lymphome \u00e0 cellules du manteau (LCM) en rechute ou r\u00e9fractaire qui ont \u00e9t\u00e9 pr\u00e9c\u00e9demment trait\u00e9s par un inhibiteur de la BTK.<\/li>\n<li>Dans l\u2019\u00e9tude de Phase 1\/2 BRUIN (\u00e9tude 18001), les patients atteints d\u2019un LCM en rechute ou r\u00e9fractaire et pr\u00e9trait\u00e9s par un inhibiteur de la BTK ont atteint un taux de r\u00e9ponse objective de 56,7 % avec une dur\u00e9e de r\u00e9ponse m\u00e9diane de 17,6 mois. Parmi les patients r\u00e9pondeurs, 18,9 % ont obtenu une r\u00e9ponse compl\u00e8te.\n<p style=\"text-align: right;\"><em>D&#8217;apr\u00e8s un communiqu\u00e9 de presse de Lilly le 6 novembre 2023.<\/em><\/p>\n<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Lilly annonce l\u2019obtention d\u2019une autorisation de mise sur le march\u00e9 conditionnelle dans l\u2019UE pour Jaypirca\u00ae(pirtobrutinib), le premier et le seul inhibiteur r\u00e9versible de la tyrosine kinase de Bruton (BTK) approuv\u00e9 [&hellip;]<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[1],"tags":[],"ppma_author":[441],"class_list":["post-17241","post","type-post","status-publish","format-standard","hentry","category-non-classe","author-admin6779"],"aioseo_notices":[],"authors":[{"term_id":441,"user_id":1,"is_guest":0,"slug":"admin6779","display_name":"HematoStat.net","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/4f64711e55fa3c9401676697c4783cec15305a6f940a0f120048b6141a611347?s=96&d=mm&r=g","first_name":"HematoStat.net","last_name":"","user_url":"http:\/\/www.hematostat.net","description":""}],"_links":{"self":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/posts\/17241","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/comments?post=17241"}],"version-history":[{"count":4,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/posts\/17241\/revisions"}],"predecessor-version":[{"id":17245,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/posts\/17241\/revisions\/17245"}],"wp:attachment":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/media?parent=17241"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/categories?post=17241"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/tags?post=17241"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/ppma_author?post=17241"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}